Brian Singerman has a been a member of the Founders Fund investment team since 2008.
After graduating from Stanford University with a BS in Computer Science, Brian joined a start-up, There, Inc., as a software engineer. He was recruited to Google in March 2004, and spent the next four years as an engineer and executive at the company, where, among other projects, he founded iGoogle.
While at Google, Brian started his career as an investor, founding his own angel fund, the XGYC Fund, seeking early-stage opportunities with businesses that challenge the status quo. At Founders Fund, Brian relentlessly seeks out companies that can deliver massive returns to investors while also providing real value to humankind. He invests across all sectors and stages, with a particular passion for companies reinventing huge industries like healthcare, biotechnology and education. Brian sits on the boards of Affirm, AltSchool, Emerald Therapeutics, and Oscar. He was also a board director at Misfit, prior to the company’s acquisition by Fossil in 2015, and Stemcentrx, before the company was acquired by AbbVie in 2016 in the largest private biotech acquisition of all time.